HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Abstract
Abnormal neuronal aggregates of alpha-internexin and the three neurofilament (NF) subunits, NF-L, NF-M, and NF-H have recently been identified as the pathological hallmarks of neuronal intermediate filament (IF) inclusion disease (NIFID), a novel neurological disease of early onset with a variable clinical phenotype including frontotemporal dementia, pyramidal and extrapyramidal signs. alpha-Internexin, a class IV IF protein, a major component of inclusions in NIFID, has not previously been identified as a component of the pathological protein aggregates of any other neurodegenerative disease. Therefore, to determine the specificity of this protein, alpha-internexin immunohistochemistry was undertaken on cases of NIFID, non-tau frontotemporal dementias, motor neuron disease, alpha-synucleinopathies, tauopathies, and normal aged control brains. Our results indicate that class IV IF proteins are present within the pleomorphic inclusions of all cases of NIFID. Small subsets of abnormal neuronal inclusions in Alzheimer's disease, Lewy body diseases, and motor neuron disease also contain epitopes of alpha-internexin. Thus, alpha-internexin is a major component of the neuronal inclusions in NIFID and a relatively minor component of inclusions in other neurodegenerative diseases. The discovery of alpha-internexin in neuronal cytoplasmic inclusions implicates novel mechanisms of pathogenesis in NIFID and other neurological diseases with pathological filamentous neuronal inclusions.
AuthorsNigel J Cairns, Kunihiro Uryu, Eileen H Bigio, Ian R A Mackenzie, Marla Gearing, Charles Duyckaerts, Hideaki Yokoo, Yoichi Nakazato, Evelyn Jaros, Robert H Perry, Steven E Arnold, Virginia M-Y Lee, John Q Trojanowski
JournalActa neuropathologica (Acta Neuropathol) Vol. 108 Issue 3 Pg. 213-23 (Sep 2004) ISSN: 0001-6322 [Print] Germany
PMID15170578 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carrier Proteins
  • Intermediate Filament Proteins
  • alpha-internexin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain (metabolism, pathology)
  • Carrier Proteins (metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Inclusion Bodies (metabolism, pathology)
  • Intermediate Filament Proteins
  • Intermediate Filaments (metabolism, pathology)
  • Male
  • Middle Aged
  • Neurodegenerative Diseases (metabolism, pathology)
  • Neurons (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: